CI Private Wealth »

Relmada Therapeutics shares owned by CI Private Wealth

Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by CI Private Wealth from 13F filings

Historical chart of CI Private Wealth investment in Relmada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Relmada Therapeutics held by CI Private Wealth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Relmada Therapeutics by CI Private Wealth

Quarter filed Position value Share count Share price at filing
2025-09-30 $402k 207k 1.95
2025-06-30 $120k 207k 0.58

More positions owned by CI Private Wealth

Microsoft Corporation (MSFT)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
JPMorgan Chase & Co. (JPM)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Meta Platforms Cl A (META)
Vanguard Index Fds Growth Etf (VUG)

View all positions for CI Private Wealth

Top funds holding Relmada Therapeutics

Ikarian Capital
Driehaus Capital Management
Boothbay Fund Management
Acadian Asset Management
BlackRock
Vanguard Group
AdvisorShares Investments
Geode Capital Management
Marshall Wace
Deutsche Bank Aktiengesellschaft
CI Private Wealth
Susquehanna International
Two Sigma Investments
Renaissance Technologies
Parsons Capital Management

View all funds holding Relmada Therapeutics